Health

Trump Plans Second Putin Meeting as Ukraine Talks Intensify

President Donald Trump is accelerating his diplomatic push to end the war in Ukraine, announcing a second meeting with Russian President Vladimir Putin just one day before he is...

United CEO Warns Government Shutdown Could Hit Travel Demand

United Airlines CEO Scott Kirby warned Thursday that the ongoing U.S. government shutdown could soon begin to hurt...

CDC Urges Vaccinations as U.S. Enters 2025–26 Virus Season

As temperatures drop and leaves turn golden, health experts are warning of a familiar seasonal threat: respiratory viruses....

Microsoft Ends Windows 10 Support, Pushes AI-Powered Windows 11

After a decade of service, Microsoft officially ended support for Windows 10 on Tuesday, marking the end of...

Nvidia, Microsoft, and BlackRock Lead $40B Data Center Deal

In one of the largest technology infrastructure deals ever announced, Nvidia, Microsoft, BlackRock, and Elon Musk’s xAI are...
spot_img

Poor Sleep Linked to Faster Brain Ageing

Study Finds Sleep Habits Shape Brain Health Sleep is not just rest—it is an active process that restores the body and protects the brain. A...

Breast Cancer Awareness Month 2025: Every Story Matters

Theme: Every Story is Unique, Every Journey Matters October marks Breast Cancer Awareness Month, a time to honor millions of lives affected by breast cancer...

Study Finds Most Heart Disease Cases Are Preventable

A new study published in the Journal of the American College of Cardiology reveals that nearly all cases of heart disease, stroke, or heart...

Mangos and Diabetes: A Surprising Health Ally

Mangos are often dismissed as an unhealthy choice due to their high sugar content, but new research suggests the opposite may be true. A...

Low-Cost HIV Prevention Jab to Roll Out by 2027

Affordable access to lenacapavir A twice-yearly HIV prevention injection, lenacapavir, will soon be available for just $40 per patient per year in 120 low- and...

Alzheimer’s Research Brings New Hope, Ongoing Questions

Modest advances with new drugs After decades of stalled progress, two treatments — Eli Lilly’s donanemab and Biogen and Eisai’s lecanemab — have shown the...